Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV.

Source:http://linkedlifedata.com/resource/pubmed/id/11390579

Download in:

View as

General Info

PMID
11390579